Increasing Oral Medication Adherence for Metastatic Breast Cancer Patients
Recruiting · NCT06726889 · Observational (researchers observe without assigning treatment) · Lead sponsor: European Institute of Oncology
View the official record on ClinicalTrials.gov →Interventions studied
Decision Support System (DSS)FeedbackRemindersStandard care
What this trial is about
Aim of this study is to optimize an adherence increasing intervention designed for metastatic Breast Cancer (BC) patients by applying a full factorial design in order to evaluate the optimal combination of three different intervention components.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Patients with a diagnosis of metastatic BC
- Patients with a prescription for any OAA (i.e. oral chemotherapy, endocrine therapy, and Cyclin-Dependent Kinase 4/6 Inhibitors)
- Age \>18 years old
- Patients with a personal smart phone with internet access
- Willingness and ability to comply with scheduled visits and other trial procedures
- Understanding and speaking Italian language
- Written informed consent
Exclusion criteria
- Psychiatric disorders or conditions that might impair the ability to give informed consent
- Comorbidity that may impact on compliance to study procedures
Where it is running
1 location listed.
- European Institute of Oncology - Milan, Italy